Loading...
Adalimumab for maintenance of remission in Crohn's disease
BACKGROUND: Conventional medications for Crohn's disease (CD) include anti‐inflammatory drugs, immunosuppressants and corticosteroids. If an individual does not respond, or loses response to first‐line treatments, then biologic therapies such as tumour necrosis factor‐alpha (TNF‐α) antagonists...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2020
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386457/ https://ncbi.nlm.nih.gov/pubmed/32413933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012877.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|